Vasodilator-Induced Stress in Concordance With Adenosine - VISION 302 — Presented at SCAI-ACC i2 Summit/ACC 2008

Description:

The goal of this trial was to evaluate the safety and efficacy of the selective adenosine A2A receptor agonist binodenoson for pharmacologic stress in patients at risk or with known coronary artery disease (CAD).